Cargando…
Application of engineered extracellular vesicles to overcome drug resistance in cancer
Targeted therapies have significantly improved survival rates and quality of life for many cancer patients. However, on- and off-target side toxicities in normal tissues, and precocious activation of the immune response remain significant issues that limit the efficacy of molecular targeted agents....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797956/ https://www.ncbi.nlm.nih.gov/pubmed/36591444 http://dx.doi.org/10.3389/fonc.2022.1070479 |